In vivo lymphatic imaging of a human inflammatory breast cancer model

Journal of Cancer

Volumn 5, Issue 9, 2014, Pages 774-783

  Agollah, Germaine D ^a,b   Wu, Grace ^a   Sevick Muraca, Eva M ^a   Kwon, Sunkuk ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Inflammatory breast cancer; Lymphangiogenesis; Lymphatic system; Near infrared fluorescence imaging

Indexed keywords

INDOCYANINE GREEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; IN VIVO STUDY; INFLAMMATORY BREAST CANCER; LYMPH VESSEL; LYMPHATIC DRAINAGE; MOUSE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; TUMOR CELL INOCULATION; TUMOR GROWTH;

EID: 84920922756     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.9835     Document Type: Article

References (40)

1. Hance KW, Anderson WF, Devesa SS. et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005; 97: 966-75.
2. Levine PH, Steinhorn SC, Ries LG. et al. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst. 1985; 74: 291-7.
3. Low JA, Berman AW, Steinberg SM. et al. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol. 2004; 22: 4067-74.
4. Ueno NT, Buzdar AU, Singletary SE. et al. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol. 1997; 40: 321-9.
5. Jaiyesimi IA, Buzdar AU, and Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol. 1992; 10: 1014-24.
6. Robertson FM, Bondy M, Yang W. et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin. 2010; 60: 351-75.
7. Greene FL, Page DL, Fleming ID. et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag. 2003: 255-281.
8. Yamauchi H, Woodward WA, Valero V. et al. Inflammatory breast cancer: what we know and what we need to learn. Oncologist. 2012; 17: 891-9.
9. Kwon S and Sevick-Muraca EM. Mouse phenotyping with near-infrared fluorescence lymphatic imaging. Biomed Opt Express. 2011; 2: 1403-1411.
10. Kwon S and Sevick-Muraca EM. Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods. 2010; 360: 167-72.
11. Kwon S and Sevick-Muraca EM. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol. 2007; 5: 219-31.
12. Lapinski PE, Kwon S, Lubeck BA. et al. RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J Clin Invest. 2012; 122: 733-47.
13. Burrows PE, Gonzalez-Garay ML, Rasmussen JC. et al. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A. 2013; 110: 8621-6.
14. Kwon S, Agollah GD, Wu G. et al. Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging. Biomed Opt Express. 2013; 4: 967-77.
15. Zhu B, Wu G, Robinson H. et al. Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Mol Imaging Biol. 2013; 15: 560-8.
16. Lu Y, Darne CD, Tan IC. et al. In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation. J Biomed Opt. 2013; 18: 101305.
17. Kuperwasser C, Dessain S, Bierbaum BE. et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res. 2005; 65: 6130-8.
18. Zbytek B, Carlson JA, Granese J. et al. Current concepts of metastasis in melanoma. Expert Rev Dermatol. 2008; 3: 569-585.
19. Kwon S, Davies-Venn C, and Sevick-Muraca EM. In vivo dynamic imaging of intestinal motions using diet-related autofluorescence. Neurogastroenterol Motil. 2012; 24: 494-7.
20. Wong SL, Balch CM, Hurley P. et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012; 30: 2912-8.
21. Alpaugh ML, Tomlinson JS, Shao ZM. et al. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 1999; 59: 5079-84.
22. Forozan F, Veldman R, Ammerman CA. et al. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer. 1999; 81: 1328-34.
23. Singh B, Cook KR, Martin C. et al. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer. Clin Exp Metastasis. 2010; 27: 233-40.
24. Filonov GS, Piatkevich KD, Ting LM. et al. Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol. 2011; 29: 757-61.
25. Shu X, Royant A, Lin MZ. et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009; 324: 804-7.
26. Proulx ST, Luciani P, Christiansen A. et al. Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis. Biomaterials. 2013; 34: 5128-37.
27. Leijte JA, van der Ploeg IM, Valdes Olmos RA. et al. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med. 2009; 50: 364-7.
28. Uren RF, Howman-Giles R, Chung DK. et al. Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes. Clin Nucl Med. 2007; 32: 312-3.
29. Lam TK, Uren RF, Scolyer RA. et al. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res. 2009; 19: 94-9.
30. Norman J, Cruse CW, Espinosa C. et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991; 162: 432-7.
31. Uren RF, Howman-Giles R, and Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003; 44: 570-82.
32. Van der Auwera I, Van Laere SJ, Van den Eynden GG. et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res. 2004; 10: 7965-71.
33. Skobe M, Hawighorst T, Jackson DG. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001; 7: 192-8.
34. Mattila MM, Ruohola JK, Karpanen T. et al. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 2002; 98: 946-51.
35. Karpanen T, Egeblad M, Karkkainen MJ. et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001; 61: 1786-90.
36. Van der Auwera I, Van den Eynden GG, Colpaert CG. et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res. 2005; 11: 7637-42
37. Padera TP, Kadambi A, di Tomaso E. et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002; 296: 1883-6.
38. Sevick-Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med. 2012; 63: 217-31.
39. Sevick-Muraca EM, Kwon S, and Rasmussen JC. Emerging lymphatic imaging technologies for mouse and man. J Clin Invest. 2014; 124: 905-14.
40. Meric-Bernstam F, Rasmussen JC, Krishnamurthy S. et al. Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents. Biomed Opt Express. 2014; 5: 183-96.